ANX007

Annexon finds more silver linings in failed eye disease trial ahead of talks with FDA
Fierce Biotech
Mon, 07/31/23 - 10:17 am
Annexon
clinical trials
geographic atrophy
ANX007
Annexon reports topline results from Phase II trial of geographic atrophy therapy
Clinical Trials Arena
Thu, 05/25/23 - 08:25 pm
Annexon
clinical trials
ANX007
vision loss
geographic atrophy